Pfizer’s J. Jean Cui explains modern drug discovery to Keck School students
By Marie Rippen
Only five percent of potential cancer drugs make it from phase I clinical trail to FDA approval, but J. Jean Cui, PhD, associate research fellow at Pfizer, beat the odds.
J. Jean Cui of Pfizer shared her perspective on drug discovery with Keck School students as part of the Careers in Science seminar series.
(Photo/Cristy Lytal)
Cui visited the Eli and Edythe Broad CIRM Center for Regenerative Medicine and Stem Cell Research on Sept. 13 to share her perspective on drug discovery with students as part of the Careers in Science seminar series, presented by the center in conjunction with the USC School of Pharmacy and the USC Center for Excellence in Research. … Read More »